Literature DB >> 15321008

The physiological rationale for oral insulin administration.

Ehud Arbit1.   

Abstract

Insulin remains the most effective and durable drug in the armamentarium for the treatment of advanced-stage diabetes. Nevertheless, clinical studies have shown that even on insulin treatment, a significant percentage of patients fail to attain lasting glycemic control. Well-recognized reasons for this failure include issues related to patients' noncompliance with an injectable drug and the late stage at which insulin is prescribed, but less explicit reasons related to the nonphysiological way insulin is currently administered are equally important. Parenteral insulin targets peripheral tissue rather than the liver with pharmacokinetics that do not replicate the normal dynamics of endogenous insulin release. Oral insulin is one of several alternative methods of insulin administration that are in clinical stages of development. The oral route of insulin delivery takes advantage of the portal-hepatic route of absorption. A review of relevant physiology is herewith provided.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321008     DOI: 10.1089/1520915041705929

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  14 in total

Review 1.  Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.

Authors:  W Blair Geho; Hans C Geho; John R Lau; Theophilus J Gana
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 2.  Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2015-03-26       Impact factor: 6.648

3.  Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Authors:  Dale S Edgerton; Melanie Scott; Ben Farmer; Phillip E Williams; Peter Madsen; Thomas Kjeldsen; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  JCI Insight       Date:  2019-02-26

4.  Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin.

Authors:  Amani Elsayed; Mayyas Al-Remawi; Nidal Qinna; Asim Farouk; Khaldoun A Al-Sou'od; Adnan A Badwan
Journal:  AAPS PharmSciTech       Date:  2011-07-15       Impact factor: 3.246

5.  Oral insulin.

Authors:  Sanjay Kalra; Bharti Kalra; Navneet Agrawal
Journal:  Diabetol Metab Syndr       Date:  2010-11-08       Impact factor: 3.320

Review 6.  Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.

Authors:  Ruth Martis; Caroline A Crowther; Emily Shepherd; Jane Alsweiler; Michelle R Downie; Julie Brown
Journal:  Cochrane Database Syst Rev       Date:  2018-08-14

Review 7.  pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Authors:  Lin Liu; WenDong Yao; YueFeng Rao; XiaoYang Lu; JianQing Gao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin.

Authors:  Shaoping Sun; Na Liang; Hiromitsu Yamamoto; Yoshiaki Kawashima; Fude Cui; Pengfei Yan
Journal:  Int J Nanomedicine       Date:  2015-05-11

9.  Recent challenges in insulin delivery systems: a review.

Authors:  M M Al-Tabakha; A I Arida
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

Review 10.  Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.

Authors:  Nutthapoom Pathomthongtaweechai; Chatchai Muanprasat
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.